Our aim is to create a robust screening/early diagnosis device for Degenerative Eye diseases. It is the world’s first adoption of Quantum Laser Technology in Vision Sciences. This device is capable of performing macular tomography based on imaging and perception of structured light which helps assess the health of macula.
Age-related Macular Degeneration (AMD) is a leading cause of irreversible blindness and visual impairment. Over 200 million people worldwide live with AMD. There are no current devices with normative data for early enough screening of AMD. Treatments like Photodynamic therapy, Anti-VEGF and AREDS 2 are available but not so effective for late stage AMD. Early diagnosis of AMD is essential.
The Centre for Eye and Vision Research (CEVR) is a research collaboration between The Hong Kong Polytechnic University and the University of Waterloo in Canada under the InnoHK initiative of the HKSAR Government. It is located at the Hong Kong Science Park, Shatin, Hong Kong. It is the first global hub performing ground-breaking research in five key areas Myopia and Eye Growth, Ocular Drug Discovery and Delivery, Vision Enhancement, Tear Film and Ocular Surface, and Advanced Optometric Technology. The mission of CEVR is to generate technologies to prevent vision loss in the aging population and preserve healthy vision.